Whither thiotepa (for patients in the USA)?

av Dardis, Christopher, Milton, Kelly, Ashby, Lynn
I publikationen J Neurooncol (2015)

Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic lit...

av Ashby, Lynn S., Smith, Kris A., Stea, Baldassarre
I publikationen World J Surg Oncol (2016)

Leptomeningeal Metastases in High-Grade Adult Glioma: Development, Diagnosis, Management, and Outcomes in a Series of 34 Patients

av Dardis, Christopher, Milton, Kelly, Ashby, Lynn, Shapiro, William
Publicerad 2014

BM-11 LEPTOMENINGEAL METASTASES IN HIGH-GRADE ADULT GLIOMA: DEVELOPMENT, DIAGNOSIS, MANAGEMENT AND OUTCOMES IN A SERIES OF 34 PATIENTS

av Dardis, Christopher, Milton, Kelly, Ashby, Lynn, Shapiro, William
Publicerad 2014

Biopsy vs. extensive resection for first recurrence of glioblastoma: is a prospective clinical trial warranted?

av Dardis, Christopher, Ashby, Lynn, Shapiro, William, Sanai, Nader
I publikationen BMC Res Notes (2015)

ATCT-04 RETROSPECTIVE ANALYSIS OF TUMOR TREATING FIELDS (TTFIELDS) IN ADULTS WITH GLIOBLASTOMA: SAFETY PROFILE OF THE OPTUNE™ MEDICAL DEVICE IN PATIENTS WITH IMPLANTED NON-PROGRAMM...

av Ashby, Lynn, Hasselle, Michael, Chowdhary, Sajeel, Fathallah-Shaykh, Hassan, Zhu, Jay-Jiguang
I publikationen Neuro Oncol (2015)

ED-39 GANGLIOGLIOMA IN CHILDREN; IDENTIFICATION OF CASES AT RISK OF DEATH DUE TO PROGRESSION FOLLOWING INITIAL SURGERY

av Zieman, Glynnis, Dardis, Christopher, Gomes, Andrea, Scheck, Adrienne, Eschbacher, Jennifer, Coons, Stephen, Ashby, Lynn
Publicerad 2014

ACTR-15. THERAPEUTIC KETOGENIC DIET (KD) WITH RADIATION AND CHEMOTHERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA – PRELIMINARY RESULTS FROM NCT02046187

av Dardis, Chris, Renda, Leonora, Honea, Norissa, Smith, Kris, Nakaji, Peter, Ashby, Lynn S, Scheck, Adrienne C
I publikationen Neuro Oncol (2017)

NCOG-01. NEUROCOGNITIVE FUNCTION (NCF) AND QUALITY OF LIFE (QOL) RESULTS FROM A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH RISK LOW-GRADE GLIOMAS

av Wefel, Jeffrey, Pugh, Stephanie, Choucair, Ali, Fisher, Barbara, Fox, Sherry, Meyers, Christina, Ashby, Lynn, Mikkelsen, Tom, Glass, Jon, Yu, Michael, Howard, Steven, Movsas, Benjamin, Mehta, Minesh
I publikationen Neuro Oncol (2019)

Atypical Teratoid Rhabdoid Tumor: Two Case Reports and an Analysis of Adult Cases with Implications for Pathophysiology and Treatment

av Dardis, Christopher, Yeo, Jared, Milton, Kelly, Ashby, Lynn S., Smith, Kris A., Mehta, Shwetal, Youssef, Emad, Eschbacher, Jenny, Tucker, Kathy, Dawes, Laughlin, Lambie, Neil, Algar, Elizabeth, Hovey, Elizabeth
I publikationen Front Neurol (2017)

Phase I/II Trial of Temozolomide (TMZ), Motexafin Gadolinium (MGd), and 60 Gy Fractionated Radiation (RT) for Newly Diagnosed Supratentorial Glioblastoma Multiforme (GBM): Final Re...

av Brachman, David G., Pugh, Stephanie L, Ashby, Lynn S., Thomas, Theresa A., Dunbar, Erin M., Narayan, Samir, Robins, H. Ian, Bovi, Joseph A., Rockhill, Jason K., Won, Minhee, Curran, Walter P.
I publikationen Int J Radiat Oncol Biol Phys (2015)

IT-30 ReACT: A PHASE II STUDY OF RINDOPEPIMUT VACCINE (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA

av Reardon, David, Schuster, James, Tran, David, Fink, Karen, Nabors, Louis, Li, Gordon, Lukas, Rimas, Desjardins, Annick, Ashby, Lynn, Duic, J. Paul, Aneiro, Lynn, Hawthorne, Thomas, Green, Jennifer, Yellin, Michael, Davis, Thomas, Sampson, John
Publicerad 2014

ACTR-13. FINAL RESULTS WITH CHEMORADIOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIAL TUMORS FROM NRG ONCOLOGY/RTOG 9402

av Lassman, Andrew, Won, Minhee, Gregory Cairncross, J, Shaw, Edward, Ashby, Lynn, Souhami, Luis, Laack, Nadia, Fink, Karen, Macdonald, David, Bahary, Jean-Paul, Hartford, Alan, Whitton, Anthony, Werner-Wasik, Maria, Laperriere, Normand, Suh, John, Robinson, Clifford, Mehta, Minesh
I publikationen Neuro Oncol (2019)

Intermediate-risk meningioma: Initial outcomes from NRG Oncology RTOG 0539

av Rogers, Leland, Zhang, Peixin, Vogelbaum, Michael A., Perry, Arie, Ashby, Lynn S., Modi, Jignesh M., Alleman, Anthony M., Galvin, James, Brachman, David, Jenrette, Joseph M., De Groot, John, Bovi, Joseph A., Werner-Wasik, Maria, Knisely, Jonathan P. S., Mehta, Minesh P.
I publikationen J Neurosurg (2017)

Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, contr...

av Nabors, L. Burt, Fink, Karen L., Mikkelsen, Tom, Grujicic, Danica, Tarnawski, Rafal, Nam, Do Hyun, Mazurkiewicz, Maria, Salacz, Michael, Ashby, Lynn, Zagonel, Vittorina, Depenni, Roberta, Perry, James R., Hicking, Christine, Picard, Martin, Hegi, Monika E., Lhermitte, Benoit, Reardon, David A.
I publikationen Neuro Oncol (2015)

ATIM-06. PHASE 2 TRIAL OF SL-701 + BEVACIZUMAB IN PATIENTS WITH PREVIOUSLY TREATED GLIOBLASTOMA (GBM) MEETS PRIMARY ENDPOINT OF OS-12, WITH PRELIMINARY CORRELATION BETWEEN LONG-TER...

av Peereboom, David, Nabors, L Burt, Kumthekar, Priya, Badruddoja, Michael, Fink, Karen, Lieberman, Frank, Phuphanich, Surasak, Dunbar, Erin, Walbert, Tobias, Schiff, David, Tran, David, Ashby, Lynn, Butowski, Nicholas, Iwamoto, Fabio, Lindsay, Ross, Bullington, John, Schulder, Michael, Sherman, Jonathan, Brooks, Chris, Reardon, David
I publikationen Neuro Oncol (2018)

CTNI-57. LOW-RISK MENINGIOMA: OUTCOMES FROM NRG ONCOLOGY/RTOG 0539

av Rogers, Leland, Pugh, Stephanie, Vogelbaum, Michael, Perry, Arie, Ashby, Lynn, Modi, Jignesh, Alleman, Anthony, Youssef, Emad, Braunstein, Steve, Bovi, Joseph, de Groot, John, Whitton, Anthony, Lindhorst, Scott, Taylor, Nicholas, Shrieve, Dennis, Shu, Hui-Kuo, Machtay, Mitchell, Mishra, Mark, Robinson, Clifford, Mehta, Minesh
I publikationen Neuro Oncol (2020)

MNGI-08. HIGH-RISK MENINGIOMA: INITIAL OUTCOMES FROM NRG ONCOLOGY/RTOG-0539

av Rogers, Leland, Zhang, Peixin, Vogelbaum, Michael, Perry, Arie, Ashby, Lynn S, Modi, Jignesh, Alleman, Anthony, Galvin, James, Fogh, Shannon, Youssef, Emad, Deb, Nimsha, Kwok, Young, Robinson, Clifford G, Shu, Hui-Kuo, Fisher, Barbara J, Panet-Raymond, Valerie, McMillan, William, de Groot, John, Mehta, Minesh P
I publikationen Neuro Oncol (2017)

ATIM-10. PHASE 2 TRIAL OF SL-701, A NOVEL IMMUNOTHERAPY COMPRISED OF SYNTHETIC SHORT PEPTIDES AGAINST GBM TARGETS IL-13Rα2, EphA2, AND SURVIVIN, IN ADULTS WITH SECOND-LINE RECURREN...

av Reardon, David, Nabors, Burt, Kumthekar, Priya, Badruddoja, Michael, Fink, Karen, Lieberman, Frank, Hu, Jethro, Dunbar, Erin, Walbert, Tobias, Schiff, David, Sherman, Jonathan, Tran, David, Ashby, Lynn S, Butowski, Nicholas, Iwamoto, Fabio, Moertel, Christopher, Schulder, Michael, Chen, Janice, Bullington, John, Shemesh, Shay, Brooks, Christopher, Goswami, Trishna, Peereboom, David M
I publikationen Neuro Oncol (2017)

Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma

av Batchelor, Tracy T., Mulholland, Paul, Neyns, Bart, Nabors, L. Burt, Campone, Mario, Wick, Antje, Mason, Warren, Mikkelsen, Tom, Phuphanich, Surasak, Ashby, Lynn S., DeGroot, John, Gattamaneni, Rao, Cher, Lawrence, Rosenthal, Mark, Payer, Franz, Jürgensmeier, Juliane M., Jain, Rakesh K., Sorensen, A. Gregory, Xu, John, Liu, Qi, van den Bent, Martin
Publicerad 2013